A Research Report On Stock Investment Value Analysis For Shenzhen Accord Pharmaceutical Co., Ltd.

With the ever-increasing economic environment and the significant improvement on people's living conditions, Residents of financial investment consciousness is more and more strong. As a result, the subject of investment and money management has grabually become common People's Daily homework. Until Dec.31th,2010, there are total 2,747 listed companies, of which 2,063 listed in stock markets of Shanghai and Shenzhen main board,531 in SMES (Small and Medium-sized Enterprises) board, and 153 in GEM (Growth Enterprises Market) board. It is tremendously significant to select potential investment industries and low-valued stocks, and analysis them reasonably.Analysis value of the object is an important content of stock investment。If it's worth investment should buy, otherwise they should be sell. But in real investment process, determine the value of investment target is difficult. Which industry and varieties to choose should been deliberate deeply. Time creates values. Seeking for the relatively low appraise or those fall within the value zone, as well as long-term possession of those which feature basic infrastructure and core competitive advantages are both wise for investors.Caused by the global recession in the periods from 2007～2009, majorities of industries had been severely struck, but it surprisingly turned out the pharmaceutical industries survived and seemed to keep rolling on steadily and prosperously. With the boom of economy, appearance of aging problem, enhance of awareness of health, plus the improvement and spread of medical insurance, it turns out that the overall long-term trend of the industry seems upward in decades. As one of the few A stocks that stand out in the boards as well as being featured consumption and emerging, mid-long-term medical boards have always been the prior options among investors. However, due to the overestimates of relative appraise of medical boards, Medicine policy rules also need time to enact and implementation, the new policy of the medicine pricing and the anti-commercial bribery policies showing storm to trend, Also, the extent that the stocks in the medical boards affected is different.The report chooses Accord Pharmaceutical CO., Ltd. (000028, Accord B200028) as the study object. It provides profit prediction and value estimate through analysis of development trends and profit models of pharmaceutical industry and various branches of the company. The report also includes research of evaluation methods of listed stocks, analysis of internal investment value of Accord Pharmaceutical, comparison with similar listed corporations (competitors). Plus, it points out the sphere of application of the evaluation method, as well as Accord Pharmaceutical's status and core competitiveness in the industry. The passage introduces the investment value of Accord Pharmaceutical's stock from the fundamental. Moreover, It provides investors and supervision authorities with examples and advice of investment analysis combined with its performance in secondary market.